NR4A1 can significantly inhibit fibroblast activation to repress intestinal fibrosis during the development of inflammatory bowel disease and vocal fold fibrosis (Pulakazhi Venu et al. 2021; Hiwatashi et al. 2018). The gene discussed is NR4A1; the disease is inflammatory bowel disease.